A pancreas adenocarcinoma szűrési lehetőségei

Gábor Gieszinger; László Czakó

doi:10.59063/mba.2026.79.3.1

Dr. Gieszinger Gábor Szegedi Tudományegyetem, Szent-Györgyi Albert Klinikai Központ, Belgyógyászati Klinika, Gasztroenterológiai Centrum, Szeged https://orcid.org/0009-0004-5641-1682
Dr. Czakó László Szegedi Tudományegyetem, Szent-Györgyi Albert Klinikai Központ, Belgyógyászati Klinika, Gasztroenterológiai Centrum, Szeged https://orcid.org/0000-0002-6331-0802

DOI: https://doi.org/10.59063/mba.2026.79.3.1

Kulcsszavak: pancreasrák, adenocarcinoma, szűrés, utánkövetés, diabetes mellitus, endoszkópos ultrahang

Absztrakt

A pancreas adenocarcinoma élettartam incidenciája 1,3%, viszont az incidenciája és mortalitása is egyaránt növekvő tendenciát mutat. A daganat igen rossz prognózisú, az 5 éves túlélés 10–13% körül van. Az igen gyakori előfordulásra és rossz kimenetelre való tekintettel merül fel a kérdés, hogy szűréssel javítható-e ezen betegség prognózisa, és ha igen, kiket és hogyan is szűrjünk?

Hivatkozások

Sung H, Ferlay J, Siegel RL és mtsai: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and ortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71: 209-249. https://doi.org/10.3322/caac.21660

Zhang Q, Zeng L, Chen Y és mtsai: Pancreatic Cancer Epidemiology, Detection, and Management. Gastroenterol ResPract 2016; 2016: 1-10. https://doi.org/10.1155/2016/8962321

Habbe N, Langer P, Sina-Frey M és mtsai: Familial Pancreatic Cancer Syndromes. Endocrinol Metab Clin North Am 2006; 35: 417-430. https://doi.org/10.1016/j.ecl.2006.02.016

Greer JB, Lynch HT, Brand RE: Hereditary pancreatic cancer: A clinical perspective. Best Pract Res Clin Gastroenterol 2009; 23: 159-170. https://doi.org/10.1016/j.bpg.2009.02.001

Salvatore T, Marfella R, Rizzo MR és mtsai: Pancreatic cancer and diabetes: A two-way relationship in the perspective of diabetologist. Int J Surgery 2015; 21 Suppl 1: S72-77. https://doi.org/10.1016/j.ijsu.2015.06.063

Illés D, Czakó L: A pancreascarcinoma korszerű kezelése. Central European Journal of Gastroenterology and Hepatology/Gasztroenterológiai és Hepatológiai Szemle 2016; 2: 176-82.

Lee J, Creanga-Marariu I, Németh J és mtsai: Association of Pancreatic Cancer with Acute Pancreatitis: A Systematic Review and Meta-Analysis. Clin. Transl. Gastroenterol 2026; 17. https://doi.org/10.14309/ctg.0000000000000927

Hussein T, Mátrai P, Vass V és mtsai: Onset of pancreatic cancer before and after acute pancreatitis: A multicenter longitudinal cohort study. Pancreatology 2025; 25, 29-34. https://doi.org/10.1016/j.pan.2025.07.325

Chari ST, Leibson CL, Rabe KG és mtsai: Pancreatic Cancer-Associated Diabetes Mellitus: Prevalence and Temporal Association With Diagnosis of Cancer. Gastroenterology 2008; 134: 95-101.

Mellenthin C, Balaban VD, Dugic A és mtsai: Risk Factors for Pancreatic Cancer in Patients with New-Onset Diabetes: A Systematic Review and Meta-Analysis. Cancers (Basel) 2022; 14: 4684. https://doi.org/10.3390/cancers14194684

Klatte DCF, Wallace MB, Löhr M és mtsai: Hereditary pancreatic cancer. Best Pract Res Clin Gastroenterol 2022; 58-59. 101783

Aslanian HR, Lee JH, Canto MI: AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review. Gastroenterology 2020; 159: 358-362 https://doi.org/10.1053/j.gastro.2020.03.088

Vilela A, Quingalahua E, Vargas A és mtsai: Global Prealence of Pancreatic Cystic Lesions in the General Population on Magnetic Resonance Imaging: A Systematic Review and Metaanalysis. Clin Gastroenterol Hepatol 2024; 22: 1798-1809.e6 https://doi.org/10.1016/j.cgh.2024.02.018

Moutinho-Ribeiro P, Macedo G, Melo SA: Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble? Front Endocrinol (Lausanne) 2019; 9: 779. https://doi.org/10.3389/fendo.2018.00779

Singhi AD, Koay EJ, Chari ST és mtsai: Early Detection of Pancreatic Cancer: Opportunities and Challenges. Gastroenterology 2019; 156: 2024-2040. https://doi.org/10.1053/j.gastro.2019.01.259

Săftoiu A, Hassan C, Areia M és mtsai: Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2020; 12; 52: 293-304. https://doi.org/10.1055/a-1104-5245

Chari ST, Wu B, Lopez C és mtsai: Risk of Pancreatic Cancer in Glycemically Defined New-Onset Diabetes: A Prospective Cohort Study. Gastroenterology 2026; 170: 106-117. https://doi.org/10.1053/j.gastro.2025.06.025

Goggins M, Overbeek KA, Brand R és mtsai: Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut 2020; 69: 7-17. https://doi.org/10.1136/gutjnl-2019-319352corr1

Khan S, Chari ST: ENDPAC model for defining a high-risk group for pancreatic cancer: Strengths, limitations and the way forward. Pancreatology 2025; 25: 1404-1406 https://doi.org/10.1016/j.pan.2025.11.007

Signoretti M, Bruno MJ, Zerboni G és mtsai: Results of surveillance in individuals at high‐risk of pancreatic cancer: A systematic review and meta‐analysis. United European Gastroenterol J 2018; 6: 489-499. https://doi.org/10.1177/2050640617752182

Corral JE, Mareth KF, Riegert-Johnson DL és mtsai: Diagnostic Yield From Screening Asymptomatic Individuals at High Risk for Pancreatic Cancer: A Meta-analysis of Cohort Studies. Clin Gastroenterol Hepatol 2019; 17: 41-53.

https://doi.org/10.1016/j.cgh.2018.04.065

Pouw RE, Barret M, Biermann K és mtsai: Endoscopic tissue sampling - Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2021; 53: 1174-1188. https://doi.org/10.1055/a-1611-5091

Dumonceau JM, Deprez P, Jenssen C és mtsai: Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated January 2017. Endoscopy 2017; 49: 695-714. https://doi.org/10.1055/s-0043-109021

Săftoiu A, Vilmann P, Dietrich CF és mtsai: Quantitative contrast-enhanced harmonic EUS in differential diagnosis of focal pancreatic masses (with videos). Gastrointest Endosc 2015; 82: 59-69. https://doi.org/10.1016/j.gie.2014.11.040

European Study Group on Cystic Tumours of the Pancreas: European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018; 67: 789-804. https://doi.org/10.1136/gutjnl-2018-316027

Ohtsuka T, Fernandez-del Castillo C, Furukawa T és mtsai: International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology 2024; 24: 255-270. https://doi.org/10.1016/j.pan.2023.12.009

Scarà S, Bottoni P, Scatena R: CA 19-9: Biochemical and Clinical Aspects. Adv Exp Med Biol 2015; 867: 247-260. https://doi.org/10.1007/978-94-017-7215-0_15

Tripathi S, Tabari A, Mansur A és mtsai: From Machine Learning to Patient Outcomes: A Comprehensive Review of AI in Pancreatic Cancer. Diagnostics 2024; 14: 174. https://doi.org/10.3390/diagnostics14020174

Klatte DCF, Boekestijn B, Wasser MNJM és mtsai: Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up. J Clin Oncol 2022; 40: 3267-3277. https://doi.org/10.1200/JCO.22.00194

Overbeek KA, Cahen DL, Kamps A és mtsai: Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance. Fam Cancer 2020; 19: 247-258. https://doi.org/10.1007/s10689-020-00171-8

Paiella S, Secchettin E, Lionetto G és mtsai: Surveillance of Individuals at High Risk of Developing Pancreatic Cancer. Ann Surg 2024; 279: 37-44. https://doi.org/10.1097/SLA.0000000000006094